Portal de investigación
ESTUDIO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE UN TRATAMIENTO QUE COMBINA TROPIFEXOR (LJN452) Y CENICRIVIROC (CVC) EN PACIENTES ADULTOS CON ESTEATOHEPATITIS NO ALCOHÓLICA (EHNA) Y FIBROSIS HEPÁTICA.
Datos básicos
- Protocolo:
- CLJC242A2201J
- EUDRACT:
- 2017-004208-24
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2018
- Año de finalización:
- 2022
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".
Di Maira T; (...); Berenguer M
Article. 10.1097/TP.0000000000002987. 2020
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C.; (...); Weiskirchen, Ralf
Article. 10.3390/biomedicines11020420. 2023
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1371/journal.pone.0228351. 2020
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Access to liver transplant for women in Spain: a national registry analysis
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).
Garcia Morales, Natalia; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2024.502220. 2024
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.
Gitto S; (...); Berenguer M
Editorial Material. 10.1155/2019/8691502. 2019
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha, Ryan; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004803. 2023
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
Tejedor, Marta, Selzner, Nazia, Berenguer, Marina
Article. 10.1097/TP.0000000000004163. 2022
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68 Ga-DOTATOC PET/CT, 68 Ga-DOTATOC PET/MRI and 99m Tc-octreotide SPECT/CT. What does each scan provide?
Prado-Wohlwend, S.; (...); Bello-Arques, P.
Editorial Material. 10.1016/j.remn.2020.05.012. 2021
Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals
Fernandez, A.; (...); Salcedo, M. M.
Meeting Abstract. 2023
ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE
Sanchez-Monteagudo, A; (...); Berenguer, M
Meeting Abstract. 2019
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)
Nyssen, OP; (...); Gisbert, JP
Article. 10.1111/hel.12722. 2020
Brain abscesses in early post-liver transplantation.
Mínguez Sabater A; (...); Prieto Castillo M
Case Reports. 10.1016/j.eimc.2021.02.002. 2021
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.
Mas VR, Bardhi E, Berenguer M
Article. 10.1097/TP.0000000000003816. 2021
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simao, Andre Lopes; (...); Castro, Rui E
Article. 10.1016/j.jhepr.2023.100697. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.
Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose
Meeting Abstract. 2019
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV; (...); Villamil A
Article. 10.14309/ajg.0000000000003029. 2024
Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
Reig, Anna; (...); Pares, Albert
Meeting Abstract. 2020
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.
Stephens C; (...); Andrade RJ
Article. 10.1016/j.jhep.2021.01.029. 2021
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
Rodríguez M; (...); García-Samaniego J
Article. 10.1016/j.gastrohep.2020.03.011. 2020
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley, Kris V; (...); Villamil, Alejandra
Article. 10.14309/ajg.0000000000003153. 2024
Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".
Gitt S; (...); Berenguer M
Correction. 10.1155/2020/4305190. 2020
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
COVID-19 and liver transplantation
Editorial Material. 10.1038/s41575-020-0347-z. 2020
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.
Rodríguez-Perálvarez M; (...); Bernal-Bellido C
Article. 10.1111/ajt.17021. 2022
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2024
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Marcos, AC; (...); Pons, JA
Meeting Abstract. 2021
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Caballero-Marcos, A; (...); Pons, JA
Article. 10.1111/ajt.16599. 2021
Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain
Hernandez-Evole, H, Briz-Redon, A, Berenguer, M
Article. 10.4254/wjh.v12.i6.277. 2020
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; (...); Berenguer, Marina
Article. 10.1016/j.gastrohep.2021.03.017. 2022
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA
Minguez, Alejandro; (...); Berenguer, Marina
Meeting Abstract. 2021
Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study
Minguez, A.; (...); Berenguer, M.
Meeting Abstract. 2022
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
Caballero-Marcos, Aranzazu; (...); Salcedo, Magdalena
Article. 10.1002/lt.26389. 2022
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; (...); Quer J
Article. 10.1016/j.antiviral.2019.104694. 2020
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Ampuero, Javier; (...); Romero-Gomez, Manuel
Article. 10.1111/liv.14898. 2021
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
Perricone, G; (...); European Liver Intestine Transpla
Article. 10.1111/liv.13878. 2018
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)
De Vincentis, A.; (...); Conde, Isabel
Correction. 2025
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
De Vincentis, Antonio; (...); Carbone, Marco
Article. 10.1016/j.cgh.2024.05.008. 2024
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/liv.15766. 2024
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis.
Ampuero J; (...); Del Pozo Maroto E
Article. 10.1016/j.cgh.2019.05.051. 2020
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/apt.16100. 2021
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
Distinct features of hepatitis delta in a Mediterranean setting
Hernandez-Evole, H, Berenguer-Haym, M
Meeting Abstract. 10.1016/S0618-8278(19)30486-4. 2019
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study
Tellez, Luis; (...); Albillos, Agustin
Article. 10.1111/apt.16926. 2022
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi, Paolo Angelo; (...); Belli, Luca Saverio
Article. 10.3389/ti.2023.10954. 2023
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
Londoño MC; (...); García-Buey L
Article. 10.1371/journal.pone.0221567. 2019
Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)
Puigvehi, M; (...); Carrion, JA
Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
Efficacy of second-line regimens in SPain: Results from the EuroPean Registry on H. Pylori management (HP-EuReg)
Caldas, M; (...); Gisbert, JP
Meeting Abstract. 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Crespo, J; (...); Antolin, GS
Article. 10.17235/reed.2019.6700/2019. 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
Crespo J; (...); Sánchez Antolín G
Article. 10.1016/j.gastrohep.2019.09.002. 2019
Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis
Tinguely, Pascale; (...); Spiro, Michael
Article. 10.1111/ctr.14453. 2021
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.
Pollok, Joerg M.; (...); Spiro, Michael
Article. 10.1016/S2468-1253(22)00268-0. 2023
Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.
Colmenero J; (...); Pons JA
Article. 10.1016/j.jhep.2020.07.040. 2021
Equally Interchangeable? How Sex and Gender Affect Transplantation
Melk, A; (...); Berenguer, M
Review. 10.1097/TP.0000000000002655. 2019
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).
Ampuero J; (...); Romero-Gómez M
Correction. 10.1016/j.jhep.2020.06.018. 2020
Ertapenem neurotoxicity in liver transplantation.
Martinez Delgado, Sara; (...); Conde, Isabel
Article. 10.17235/reed.2021.8469/2021. 2022
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.
Cillo U; (...); Selzner N
Review. 10.3389/ti.2022.10915. 2022
European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.
Caldas M; (...); Hp-EuReg Investigators
Article. 10.3390/antibiotics10010013. 2020
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; (...); Zubair H
Article. 10.3389/ti.2023.11358. 2023
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
Salcedo, Magdalena; (...); Line, Pal-Dag
Article. 10.1097/TP.0000000000003997. 2022
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.
Marino, Zoe; (...); Berenguer, Marina
Article. 10.1097/HEP.0000000000001105. 2024
EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP
Mendez, Zoe Marino; (...); Berenguer, Marina
Meeting Abstract. 2024
Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up
Marino, Zoe; (...); Berenguer, Marina
Meeting Abstract. 2024
EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND
Berenguer, Marina; (...); Carbone, Marco
Meeting Abstract. 2021
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
Fat, cancer, the gut-liver axis and rare liver diseases.
Editorial Material. 10.1016/j.jhepr.2020.100189. 2020
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1097/TXD.0000000000001599. 2024
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.
Rodríguez-Perálvarez ML; (...); Gastaca M
Article. 10.1016/j.eclinm.2024.102737. 2024
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.
Sánchez-Monteagudo A; (...); Espinós C
Article. 10.1111/cge.13719. 2020
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).
Russo FP; (...); Polak WG
Article. 10.1016/j.jhep.2021.09.041. 2021
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)
Calleja, JL; (...); Pineda, JA
Article. 10.1016/j.gastrohep.2018.07.010. 2018
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Heat stroke and fulminant hepatitis: Conservative management or liver transplant?
Ladrón Abia P; (...); Berenguer Haym MC
Letter. 10.1016/j.gastrohep.2020.11.004. 2021
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco
Article. 10.1186/s13293-021-00368-1. 2021
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Suarez, E; (...); Simon, MA
Article. 10.1097/MEG.0000000000001289. 2019
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19
Del Hoyo, J.; (...); Aguilera, V
Editorial Material. 2020
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
Del Hoyo J; (...); Aguilera V
Editorial Material. 10.1111/jgh.15174. 2020
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Andrade, Rita; (...); Cardoso, Joana
Article. 10.3390/cancers17030500. 2025
Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1016/j.cgh.2024.10.014. 2024
Immunosuppression in liver transplant.
Di Maira T, Little EC, Berenguer M
Review. 10.1016/j.bpg.2020.101681. 2020
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
IMPACT OF COMORBIDITIES ON LIVER TRANSPLANTATION: A PROSPECTIVE AND MULTICENTRIC ANALYSIS
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Impact of comorbidities on liver transplantation: a prospective and multicentric study
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.
Marjot, Thomas; (...); Cornberg, Markus
Article. 10.1016/j.jhep.2022.07.008. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend R.; (...); IJzermans, Jan N. M.
Article. 10.1002/jcsm.13053. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend; (...); Ijzermans, Jan
Meeting Abstract. 10.1002/jcsm.13053. 2022
Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2023
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Impact of the alveolar-arterial oxygen gradient on prognosis after liver transplantation in adults: a single-center experience
Ortega, AG; (...); Reyes, RL
Meeting Abstract. 10.1183/13993003.congress-2020.1917. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Inadequate social support decreases survival in decompensated liver cirrhosis patients.
García Morales N; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2022.04.006. 2022
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence and prognostic impact of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Angel Gomez-Bravo, Miguel
Meeting Abstract. 2020
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera
Meeting Abstract. 2023
Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study
Vinaixa, C.; (...); Aguilera, M. V.
Meeting Abstract. 2024
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation
Tsochatzis, E; (...); Berenguer, M
Review. 10.1097/TP.0000000000002433. 2019
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients (vol 102, pg 727, 2018)
Correction. 10.1097/TP.0000000000002535. 2019
International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world
Lopez-Verdugo, F; (...); Pediat Liver Transplantation
Meeting Abstract. 2021
International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Meeting Abstract. 2020
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Launch of the International Living Donor Liver Transplantation Outcomes Registry.
Staubli, Sebastian; (...); Rela, Mohamed
Letter. 10.1016/S2468-1253(23)00185-1. 2023
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome
Magaz, M; (...); Valdig
Meeting Abstract. 2021
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP
Martinez Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
Belli, LS; (...); ELITA EF-CLIF Working Grp
Article. 10.1016/j.jhep.2021.03.030. 2021
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1097/TP.0000000000004444. 2022
LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.
Artzner, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2021
Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.
Artzner, Thierry; (...); Jalan, Rajiv
Article. 10.1002/lt.26499. 2022
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gomez, E; (...); Fernandez-Rodriguez, C M
Article. 10.1111/apt.18004. 2024
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int
Article. 10.1111/ajt.16864. 2022
Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion.
Schneider S; (...); Berenguer M
Article. 10.1111/ctr.13629. 2019
Long-term patient and graft survival after liver transplantation for autoimmune hepatitis
Heinemann, Melina; (...); Schramm, Christoph
Meeting Abstract. 2020
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry.
Heinemann M; (...); Schramm C
Article. 10.1002/lt.25739. 2020
Long-term survival after living donor liver transplantation in primary sclerosing cholangitis
Liwinski, T; (...); Schramm, C
Meeting Abstract. 2021
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis
Article. 10.1016/j.dld.2024.09.002. 2024
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2022
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner, Varvara A.; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004771. 2023
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2022
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.
Herreras J; (...); Berenguer M
Article. 10.1097/TXD.0000000000000934. 2019
Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML
Article. 10.1002/hep.32149. 2021
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY
Palom, A; (...); Ferret, MAB
Meeting Abstract. 2020
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
Serrano MT; (...); Salcedo M
Article. 10.3389/ti.2022.10263. 2022
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital
Bejar-Serrano, S; (...); Benlloch, S
Article. 10.1016/j.gastrohep.2018.07.017. 2019
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
New ERAS in liver transplantation - Past, present, and next steps
Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14625. 2022
Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Non-traumatic spontaneous abdominal haemorrhage
Ballesta, M.; (...); Lerga, P. Estelles
Article. 10.1016/j.rx.2022.11.003. 2023
Non-traumatic spontaneous abdominal haemorrhage.
Ballesta M; (...); Estellés Lerga P
Article. 10.1016/j.rxeng.2022.11.004. 2023
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig, A; (...); Pares, A
Article. 10.14309/ajg.0000000000001343. 2021
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Palom, A; (...); Buti, M
Article. 10.1111/apt.16485. 2021
Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.
Ladron Abia, Pablo; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8663/2022. 2022
Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations
Sun, Li-Ying; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14640. 2022
Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena
Meeting Abstract. 2024
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation.
Cox B; (...); Selzner N
Article. 10.1097/LVT.0000000000000274. 2023
Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation
Herreras, J.; (...); Berenguer, M.
Meeting Abstract. 2019
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Marques, Patrice; (...); Sanz, Maria-Jesus
Article. 10.3390/ijms24032313. 2023
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Pilar Ballester, Maria; (...); Nicastro, Emanuele
Meeting Abstract. 2024
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D; (...); Marti-Bonmati L
Article. 10.3389/fendo.2023.1213441. 2023
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor
Sanchez-Montes, C; (...); Arguello, L
Editorial Material. 10.14309/ajg.0000000000000135. 2019
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.
Puchades Renau L; (...); Berenguer Haym M
Review. 10.17235/reed.2020.7448/2020. 2021
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Porto sinusoidal vascular liver disorder: natural history and long-term outcome
Magaz, Marta; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1016/j.jhep.2024.07.035. 2024
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow, Alfred Wei Chieh; (...); Ikegami, Toru
Article. 10.1097/TP.0000000000004770. 2023
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Berenguer, M; (...); van der Laan, LJW
Review. 10.1097/TP.0000000000003196. 2020
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; (...); Berenguer M
Article. 10.1016/j.aohep.2019.06.014. 2019
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
De Vincentis, Antonio; (...); Carbone, Marco
Meeting Abstract. 2023
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J; (...); Fernández-Rodríguez C
Article. 10.1097/HEP.0000000000000826. 2024
Predictive factors of response to corticosteroid therapy in acute severe autoinmune hepatitis: a national multicentric study
Sanchez Rodriguez, Eugenia; (...); Albillos, Agustin
Meeting Abstract. 2020
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
Llovet LP; (...); Londoño MC
Letter. 10.1016/j.cgh.2018.12.030. 2019
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR; (...); Rela M
Article. 10.1097/TP.0000000000004769. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel
Article. 10.7326/M23-2391. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
Gordon, CE; (...); Martin, P
Article. 10.7326/M19-1539. 2019
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J; (...); Molina E
Letter. 10.1136/gutjnl-2021-325700. 2021
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Minguez, Alejandro; (...); Berenguer, Marina
Article. 10.1007/s10620-024-08368-y. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
Chadha R; (...); Bhangui P
Review. 10.1097/TP.0000000000003160. 2020
Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society.
Kalisvaart, Marit; (...); Kirchner, Varvara
Article. 10.1097/TP.0000000000004183. 2022
Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.
Campos-Varela, Isabel; (...); De Martin, Eleonora
Article. 10.1097/TP.0000000000004637. 2023
Proceedings of the 28th annual congress of the international liver transplantation society.
Shaji Mathew, Johns; (...); Chadha, Ryan
Article. 10.1097/LVT.0000000000000330. 2024
Proceedings of the 29th Annual Congress of the International Liver Transplantation Society.
Patel, Madhukar S; (...); Rammohan, Ashwin
Article. 10.1097/LVT.0000000000000593. 2025
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Prognosis of severe HBV reactivation in Western countries: role of the MELD score
Poli, E; (...); Coilly, A
Meeting Abstract. 2021
Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict
Silva, Silvia Gomes; (...); Cardoso, Joana
Meeting Abstract. 2024
Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org
Turner, B.; (...); Salinas, C. Hidalgo
Meeting Abstract. 2023
Re: Tacrolimus Trough Concentrations after Liver Transplantation: .
Di Maira T; (...); Berenguer M
Letter. 10.1097/TP.0000000000003087. 2020
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.
Manuel Sousa J; (...); Manzanares A
Article. 10.1371/journal.pone.0225061. 2019
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
Crespo, Javier; (...); Calleja, Jose Luis
Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023
Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
Gratacos, Jordi; (...); Pose, Elisa
Meeting Abstract. 2023
Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments
Giuliani, Tommaso; (...); Lopez-Andujar, Rafael
Article. 10.1159/000539460. 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.
Gratacos-Gines, Jordi; (...); Pose, Elisa
Article. 10.1097/HEP.0000000000000825. 2024
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Reproductive and pregnancy control in Wilson disease patients in Spain.
Romero-Gutiérrez M; (...); Mariño Z
Article. 10.1097/MEG.0000000000002831. 2024
Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Selective Indication of T-Tube in Liver Transplantation: Prospective Validation of the Results of a Randomized Controlled Trial
Lopez-Andujar, R; (...); Montalva, EM
Article. 10.1016/j.transproceed.2018.03.133. 2019
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta, Gautam; (...); Jalan, Rajiv
Article. 10.1097/HC9.0000000000000273. 2023
Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry
Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo
Meeting Abstract. 2022
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Ampuero, J; (...); Gomez, MR
Article. 10.1016/j.jhep.2020.02.028. 2020
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Berenguer, Marina; (...); GEMHEP
Article. 10.1016/j.gastrohep.2022.10.018. 2023
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Single-capsule bismuth-quadruple therapy: 3 or 4 times daily? Spanish Data from the European Registry on H. pylori Management (Hp-EuReg)
Nyssen, OP; (...); Calvet, X
Meeting Abstract. 2019
Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.
Caballero-Marcos A; (...); Salcedo M
Article. 10.1002/lt.26452. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Stretching the boundaries for liver transplant in the 21st century
Trapero-Marugan, M, Little, EC, Berenguer, M
Review. 10.1016/S2468-1253(18)30213-9. 2018
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States.
Campos-Varela I; (...); Terrault NA
Article. 10.1097/TP.0000000000003107. 2019
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Kodali, Sudha; (...); Sapisochin, Gonzalo
Article. 10.1097/LVT.0000000000000589. 2025
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
Ampuero, J; (...); Gomez, MR
Meeting Abstract. 10.1016/S0618-8278(19)30234-8. 2019
The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Palom, Adriana; (...); Buti, Maria
Meeting Abstract. 2024
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
Ampuero, J; (...); HEPAmet Registry
Article. 10.1111/apt.15015. 2018
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage
Burra, P, Berenguer, M, Pomfret, E
Article. 10.1097/TP.0000000000002507. 2019
The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.
Colmenero J, Berenguer M, Watt KD
Article. 10.1097/TP.0000000000003994. 2022
The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)
Russo, FP; (...); Polak, W
Meeting Abstract. 2021
THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2019
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study
Gorgen, A; (...); Sapisochin, G
Article. 10.1097/TP.0000000000003115. 2020
The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2022
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B; (...); Delmonico FL
Article. 10.1097/TP.0000000000004186. 2022
The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations
Tinguely, Pascale; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14642. 2022
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024
The role of prehabilitation on short-term outcomes after liver transplantation - A review of the literature and expert panel recommendations.
Vinaixa C; (...); Samuel D
Article. 10.1111/ctr.14686. 2022
The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations
Victor, David W.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14647. 2022
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
Berenguer, Marina; (...); Marino, Zoe
Meeting Abstract. 2024
Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.
Sapisochin G; (...); Mazzaferro V
Article. 10.1097/SLA.0000000000004071. 2020
Transplantation: A Priority in the Healthcare Agenda.
Muller E; (...); Potena L
Article. 10.1097/TP.0000000000005182. 2025
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection
Cabezas, J; (...); Crespo, J
Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019
Upper gastrointestinal bleeding as a complication of Brunner's gland adenoma. An unusual presentation
Herreras, J; (...); Bustamante-Balen, M
Letter. 10.1016/j.gastrohep.2018.05.020. 2019
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Validation of MELD3.0 in 2 centers from different continents.
Tejedor M; (...); Berenguer M
Article. 10.1097/HC9.0000000000000504. 2024
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Validation of MELD3.0 in two centres from different continents
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel
Meeting Abstract. 2024
Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry
Kantsedikas, Ilya; (...); Rela, Mohamed
Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024
Very early immunosuppression predicts the first-year renal function post liver transplantation
Di Maira, T.; (...); Berenguer, M.
Meeting Abstract. 2019
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1016/j.jhepr.2023.100840. 2023
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations
Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp
Review. 2022
Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study
Belli, Luca Saverio; (...); Arroyo, Vicente
Meeting Abstract. 2020
Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease
Sánchez-Monteagudo A; (...); Espinós C
Review. 10.3390/biomedicines9091100. 2021
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
Article. 10.1007/s10620-018-5429-1. 2019
Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry
Tejedor, Marta; (...); Berenguer, Marina
Meeting Abstract. 2024
Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
Tejedor, Marta; (...); Berenguer, Marina
Article. 10.3389/ti.2024.12732. 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023